Beyond question, the dysregulation of cyclin E1/CDK2 kinase activity is involved in oncogenesis in ovarian cancer [28], bladder cancer [29], and breast cancer [30], among others. The gene discussed is CCNE1; the disease is ovarian carcinoma.